Laparoscopic surgery for melanoma metastases to the adrenal gland.
The probability of developing cutaneous melanoma is now predicted to be one in 55 for males and one in 88 for females. Although melanoma is relatively uncommon compared with other malignancies such as breast (one in seven) or prostate cancer (one in six), the incidence is growing at an alarming rate. The development of novel strategies for the management of advanced disease will become even more urgent and require continued and controlled investigations over the next 10 years. Surgery is effective for the palliation of isolated resectable metastases. However, most patients with Stage IV melanoma have widespread disease and are not cured by metastasectomy. For the few individuals with isolated adrenal metastases from melanoma, complete resection appears to confer a survival advantage. New data are emerging about the efficacy and outcome of laparoscopic adrenalectomy for malignant lesions. However, the natural history of laparoscopic surgery for these lesions is still unknown. The indications for and limitations of laparoscopic adrenalectomy for metastatic melanoma are discussed.
University of Feinberg School of Medicine, Division of Gastrointestinal and Endocrine Surgery, Chicago, IL 60611-2908, USA. csturgeon@nmff.org
Cord
C
Sturgeon
Stanley P L
SP
Leong
Quan-Yang
QY
Duh
D000310:Adrenal Gland Neoplasms / Q000556:secondary* / Q000601:surgery*; D000315:Adrenalectomy / Q000379:methods*; D002986:Clinical Trials as Topic; D006801:Humans; D010535:Laparoscopy / Q000379:methods*; D008545:Melanoma / Q000556:secondary* / Q000601:surgery*; D009367:Neoplasm Staging; D011379:Prognosis; D012878:Skin Neoplasms / Q000473:pathology*; D013534:Survival